Laidlaw & Company services a wide variety of institutional money managers, including mutual funds, banks, registered investment advisors, corporations and insurance companies. We have developed long-term relationships with many of the top portfolio managers with special attention to technology and biotechnology investors.
With access to experienced teams of market makers and sales traders, Laidlaw & Company prides itself on creating liquidity in illiquid markets. We provide timely and efficient execution of transactions in both Listed and NASDAQ issues. Our trading activities include the execution of retail orders, block trades, Rule 144A transactions and corporate equity repurchases, all of which occur in a fast-paced and volatile marketplace.
- We Do Not Trade for Our Own Account
We do not inventory securities, eliminating risk to our capital base due to market fluctuations.
- We have Access to Virtually Every Broker/Dealer
We are not viewed as competition to large Wall Street firms but rather as a major source of distribution for them.
- We Are Never Motivated to Sell a Client Our Own Products
Since we hold no inventory, our objective is to locate the best investment instrument at the most competitive price available.
- We Offer State-of-the-Art Reporting Capabilities
Our Portfolio reports are customized to meet specific client needs. Reports are prepared on a periodic basis, monthly and quarterly—or even more frequently upon request.
- We Strive To Be an Extension of Our Client's Staff
We take a long-term perspective on how we serve our clients and emphasize integrity and professionalism as our top priority. Our operating philosophy is to work diligently to maintain trust and provide exceptional service based upon individual investment objectives.
For more information,
contact Craig Bonn
at
CBonn@laidlawltd.com,
Kevin Connors
at
Kevin Connors@laidlawltd.com,
or call (212) 697-5200.
